1-(2,4-Dichlorobenzenesulfonyl)-5-[2-(1H-1,2,4-triazol-1-yl)propan-2-yl]-1H-pyrazole-4-carbonitrile

Catalog No. :
ACUTSG789
CAS No. :
318469-20-4
Molecular Formula :
C15H12Cl2N6O2S
Molecular Weight :
411.27

IUPAC Name:5-(2-(1H-1,2,4-triazol-1-yl)propan-2-yl)-1-((2,4-dichlorophenyl)sulfonyl)-1H-pyrazole-4-carbonitrile

1-(2,4-Dichlorobenzenesulfonyl)-5-[2-(1H-1,2,4-triazol-1-yl)propan-2-yl]-1H-pyrazole-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$281.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2,4-Dichlorobenzenesulfonyl)-5-[2-(1H-1,2,4-triazol-1-yl)propan-2-yl]-1H-pyrazole-4-carbonitrile
IUPAC Name5-(2-(1H-1,2,4-triazol-1-yl)propan-2-yl)-1-((2,4-dichlorophenyl)sulfonyl)-1H-pyrazole-4-carbonitrile
MDL No.MFCD00202144
Molecular FormulaC15H12Cl2N6O2S
Molecular Weight411.27
SMILESN#CC1=C(C(C)(N2N=CN=C2)C)N(S(=O)(C3=CC=C(Cl)C=C3Cl)=O)N=C1
InChI KeyYJUYTZZGKRXBBC-UHFFFAOYSA-N
Synonym1-[(2,4-DICHLOROPHENYL)SULFONYL]-5-[1-METHYL-1-(1H-1,2,4-TRIAZOL-1-YL)ETHYL]-1H-PYRAZOLE-4-CARBONITRILE;1-(2,4-dichlorobenzenesulfonyl)-5-[2-(1H-1,2,4-triazol-1-yl)propan-2-yl]-1H-pyrazole-4-carbonitrile;1H-Pyrazole-4-carbonitrile, 1-[(2,4-dichlorophenyl)sulfonyl]-5-[1-methyl-1-(1H-1,2,4-triazol-1-yl)ethyl]-
CAS No.318469-20-4

Synthetic Route by SureRoute

1. ACUTSG789 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUTSG789 route product structure diagram
    ACUTSG789318469-20-4
Inquiry

2. ACUTSG789 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBSYZ572 route compound structure diagram
    ACBSYZ57241253-21-8 In Stock
  4. Then
  5. ACUTSG789 route product structure diagram
    ACUTSG789318469-20-4
Inquiry

Comments (0)